Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Treasury Shares (2016)

Historic Treasury Shares for Northwest Biotherapeutics (NWBO) over the last 3 years, with Q1 2011 value amounting to $480000.0.

  • Northwest Biotherapeutics' Treasury Shares changed 0.0% to $480000.0 in Q1 2011 from the same period last year, while for Mar 2011 it was $480000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $480000.0 for FY2010, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2016, Northwest Biotherapeutics' Treasury Shares is $8052.0.
  • In the past 5 years, Northwest Biotherapeutics' Treasury Shares ranged from a high of $1.6 billion in Q4 2012 and a low of $8052.0 during Q4 2016
  • In the last 3 years, Northwest Biotherapeutics' Treasury Shares had a median value of $1.6 million in 2012 and averaged $312.4 million.
  • Over the last 5 years, Northwest Biotherapeutics' Treasury Shares had its largest YoY gain of 9990000.0% in 2010, and its largest YoY loss of 4319.53% in 2010.
  • Quarter analysis of 3 years shows Northwest Biotherapeutics' Treasury Shares stood at $480000.0 in 2009, then changed by 0.0% to $480000.0 in 2010, then changed by 0.0% to $480000.0 in 2011.
  • Its Treasury Shares was $480000.0 in Q1 2011, compared to $480000.0 in Q4 2010 and $480000.0 in Q3 2010.